Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.6.1.44 (
AGT
)
770
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
High altitude polycythemia (HAPC) refers to the long-term living in the plateau of the hypoxia environment is not accustomed to cause red blood cell hyperplasia. The pathological changes are mainly the various organs and tissue congestion, blood stasis and hypoxia damage. Although chronic hypoxia is the main cause of HAPC, the related molecular mechanisms remain largely unclear. This study aims to explore the genetic basis of HAPC in the Chinese Han and Tibetan populations. We enrolled 100 patients (70 Han, 30 Tibetan) with HAPC and 100 healthy control subjects (30 Han, 70 Tibetan). To explore the hereditary basis of HAPC and investigate the association between
EPHA2
with
AGT
and HAPC in Chinese Han and Tibetan populations. Using the Chi-squared test and analyses of genetic models, rs2291804, rs2291805, rs3768294, rs3754334, rs6603856, rs6669624, rs11260742, rs13375644 and rs10907223 in
EPHA2
, and rs699, rs4762 and rs5051 in
AGT
showed associations with reduced HAPC susceptibility in Han populations. Additionally, in Tibetan populations, rs2478523 in
AGT
showed an increased the risk of HAPC. Our study suggest that polymorphisms in the
EPHA2
and
AGT
correlate with susceptibility to HAPC in Chinese Han and Tibetan populations.
...
PMID:Associations of high altitude polycythemia with polymorphisms in
EPHA2
and
AGT
in Chinese Han and Tibetan populations. 2888 7